Skip to main content
Premium Trial:

Request an Annual Quote

GMU Proteomics Center Obtains CAP Certification

Premium

NEW YORK (GenomeWeb) – George Mason University's Center for Applied Proteomics and Molecular Medicine has obtained accreditation from the Commission on Laboratory Accreditation of the College of American Pathologists.

According to Lance Liotta, co-chair of the center and the laboratory's medical director, the accreditation will help the facility more quickly move findings from its clinical trials into clinical use.

The accreditation will also ease submission and sharing of clinical data, noted Virginia Espina, research associate professor at the center.

"Work done under the auspices of CAP accreditation can be submitted to other regulatory agencies, such as the [US] Food and Drug Administration, without the need for re-testing, and we can perform clinical research trials with human subjects for pharmaceutical companies or other sponsors," she said in a statement.

CAP accreditation involves examination of a laboratory’s records and quality control procedures for the preceding two years as well as examination of staff qualifications, laboratory equipment, safety programs and records, and overall laboratory management.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.